Research & Development



  雲瑯放下酒碗嘆息道︰“總要有候選的法子才好,一種制度用的時間長了,總會出現漏洞,將來就怕出現——舉秀才,不知書。舉孝廉,父別居。寒素清白濁如泥,高第良將怯如雞。如果到了那種地步,恐怕會動搖我大漢的國本。”   雲瑯左右瞅瞅,他很疑惑,正要發問,只見大殿兩側就冒出來六個宮女,其中一個宮女的前胸鼓鼓的自動來到雲瑯正前面,抬手就把他的金冠給解掉了。一本道无码在线av观看成人A片   黑衣人喘著粗氣回答道︰“自然是有使者從你家中取來的!”99热青青草超碰在线   雲瑯笑道︰“大漢宰相死起來容易,他這也是一心求活不必苛責吧。”   東籬子怒眼環睜顫聲道︰“你欲焚書?”青青草超碰免费视频av   “可公孫弘根本就是一個窮鬼……”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo